🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📈 Price Surge 6.3%

        June 5, 2026

🚨 Alpha Signal: Hanwha Life Insurance Co., Ltd. (088350.KS) 📈 Price Surge 6.3%

        🚨 Alpha Bond Signal Alert
Bond Market Analysis
Hanwha Life Insurance Co., Ltd. (088350.KS) +6.3% at 2026-06-05 11:42 JST from 2026-06-05 10:00 JST

🕒 Time (Local)
🌐 English Summary
📰 Original Headline (linked)

2026-06-04 17:32 KST
SWOT-style Korean analysis of 1Q26 notes that separate net income more than doubled year-on-year (≈+103%) driven by sharply higher investment gains, while new-contract CSM, GA-based sales expansion and overseas business are highlighted as key growth opportunities despite underwriting profit remaining a task, painting an overall constructive earnings and growth outlook. (news.nate.com)
[\[SWOT 보험분석\] 한화생명, 별도 순익 2배 ↑…투자 성과 급등 속 보험손익 회복 과제](https://news.nate.com/view/20260604n33964)

2026-05-29 11:57 KST
Company IR release announces that S&P upgraded Hanwha Life’s credit rating from A to A+ with a Stable outlook, citing strong domestic market position, diversified earnings from domestic and overseas subsidiaries, and improving profitability and capital adequacy—factors that typically support lower funding costs and higher valuation multiples for the stock. (newswire.co.kr)
한화생명, S&P 신용등급 ‘A+’로 상향

2026-05-18 11:34 KST
Market note reports Hanwha Life shares up about 4.6% intraday after Kyobo Securities reiterated a Buy rating and raised its target price to 7,000 won on much better‑than‑expected 1Q26 earnings, while several other brokers also issued positive review reports, reinforcing bullish sentiment and upside potential. (stock.mk.co.kr)
한화생명, '1Q26 Review: 연결기준 당기순이익 증가 긍정적' 증권사 발표에 강세

2026-05-17 17:50 KST
Article on 2026 1Q results explains that co-CEOs have shifted sales toward higher‑margin long‑term whole‑life products, doubling the new-contract CSM multiple (from 7.8x to 9.8x) and lifting new CSM by about 25% year-on-year, with K-ICS capital ratio also improving, which is presented as strengthening profitability and solvency. (v.daum.net)
[권혁웅·이경근 한화생명 대표, 중장기납 종신보험 확대 신계약CSM배수 2배 제고 \[2026 금융사 1분기 실적\]](https://v.daum.net/v/20260517175013819?f=p)

2026-05-12 16:19 KST
Coverage of the 1Q26 earnings call states management expects annual net CSM to increase, highlights growth in protection APE and new CSM, improvement in lapse/claims experience and investment income, and maintains guidance for annual insurance profit of 500+ billion won, while indicating dividends will resume after regulatory changes—overall reinforcing a positive medium‑term earnings trajectory. (v.daum.net)
[한화생명 “연간 CSM 순증 가능…배당 재개는 제도 개선 이후” \[종합\]](https://v.daum.net/v/20260512161903467)

2026-05-12 14:13 KST
Official Newswire press release on 1Q26 results reports consolidated net profit up 29% YoY and separate net profit up 103% YoY, driven by a 25% increase in new CSM, protection-focused APE growth, improved investment returns and a 4.5ppt rise in K-ICS ratio to about 162%, underscoring stronger earnings power and capital strength. (newswire.co.kr)
한화생명, 1분기 연결 순이익 3816억원… 전년 대비 29% 증가

                                Don't miss what's next. Subscribe to Morning Espresso:

            Email address (required)

🕒 Time (Local)	🌐 English Summary	📰 Original Headline (linked)
2026-06-04 17:32 KST	SWOT-style Korean analysis of 1Q26 notes that separate net income more than doubled year-on-year (≈+103%) driven by sharply higher investment gains, while new-contract CSM, GA-based sales expansion and overseas business are highlighted as key growth opportunities despite underwriting profit remaining a task, painting an overall constructive earnings and growth outlook. (news.nate.com)	[\[SWOT 보험분석\] 한화생명, 별도 순익 2배 ↑…투자 성과 급등 속 보험손익 회복 과제](https://news.nate.com/view/20260604n33964)
2026-05-29 11:57 KST	Company IR release announces that S&P upgraded Hanwha Life’s credit rating from A to A+ with a Stable outlook, citing strong domestic market position, diversified earnings from domestic and overseas subsidiaries, and improving profitability and capital adequacy—factors that typically support lower funding costs and higher valuation multiples for the stock. (newswire.co.kr)	한화생명, S&P 신용등급 ‘A+’로 상향
2026-05-18 11:34 KST	Market note reports Hanwha Life shares up about 4.6% intraday after Kyobo Securities reiterated a Buy rating and raised its target price to 7,000 won on much better‑than‑expected 1Q26 earnings, while several other brokers also issued positive review reports, reinforcing bullish sentiment and upside potential. (stock.mk.co.kr)	한화생명, '1Q26 Review: 연결기준 당기순이익 증가 긍정적' 증권사 발표에 강세
2026-05-17 17:50 KST	Article on 2026 1Q results explains that co-CEOs have shifted sales toward higher‑margin long‑term whole‑life products, doubling the new-contract CSM multiple (from 7.8x to 9.8x) and lifting new CSM by about 25% year-on-year, with K-ICS capital ratio also improving, which is presented as strengthening profitability and solvency. (v.daum.net)	[권혁웅·이경근 한화생명 대표, 중장기납 종신보험 확대 신계약CSM배수 2배 제고 \[2026 금융사 1분기 실적\]](https://v.daum.net/v/20260517175013819?f=p)
2026-05-12 16:19 KST	Coverage of the 1Q26 earnings call states management expects annual net CSM to increase, highlights growth in protection APE and new CSM, improvement in lapse/claims experience and investment income, and maintains guidance for annual insurance profit of 500+ billion won, while indicating dividends will resume after regulatory changes—overall reinforcing a positive medium‑term earnings trajectory. (v.daum.net)	[한화생명 “연간 CSM 순증 가능…배당 재개는 제도 개선 이후” \[종합\]](https://v.daum.net/v/20260512161903467)
2026-05-12 14:13 KST	Official Newswire press release on 1Q26 results reports consolidated net profit up 29% YoY and separate net profit up 103% YoY, driven by a 25% increase in new CSM, protection-focused APE growth, improved investment returns and a 4.5ppt rise in K-ICS ratio to about 162%, underscoring stronger earnings power and capital strength. (newswire.co.kr)	한화생명, 1분기 연결 순이익 3816억원… 전년 대비 29% 증가